Tanning beds, sunlamps, and risk of cutaneous malignant melanoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 562-566

  Gallagher, Richard P ^a,b   Spinelli, John J ^a,b   Lee, Tim K ^a,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; CANCER RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA ANALYSIS; EVALUATION; HUMAN; MEDLINE; MELANOMA; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SKIN COLOR; SUNLIGHT; SYSTEMATIC REVIEW; ULTRAVIOLET RADIATION;

EPIDEMIOLOGIC STUDIES; EQUIPMENT DESIGN; HUMANS; LIGHT; MELANOMA; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 16844375565     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0564     Document Type: Short Survey

References (28)

1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risk to humans. Vol 55. Solar and ultraviolet radiation. Lyon: IARC Press; 1992.
2. Elwood JM, Jopson J. Melanoma and sun exposure; an overview of published studies. Int J Cancer 1997;73:198-203.
3. Young AR. Tanning devices-fast track to skin cancer? Pigment Cell Res 2004;17:2-9.
4. Amir Z, Wright A, Kernohan E, Hart G. Attitudes, beliefs and behavior regarding the use of sunbeds among healthcare workers in Bradford. Eur J Cancer Care 2000;9:76-9.
5. Jerkegren E, Sandreiser L, Brandberg Y, Rosdahl I. Sun-related behavior and melanoma awareness among Swedish university students. Eur J Cancer Prev 1999;8:27-34.
6. Geller AC, Colditz G, Oliveria S, et al. Use of sunscreen, sunburning rates, and tanning bed use among more than 10000 US children and adolescents. Pediatrics 2002;109:1009-14.
7. Gallagher RP, Elwood JM, Hill GB. Risk factors for cutaneous malignant melanoma: the western Canada melanoma study. Recent Results Cancer Res 1986;102:38-55.
8. Holman CDJ, Armstrong BK, Heenan PJ, et al. The causes of malignant melanoma: results from the West Australian Lions melanoma research project. Recent Results Cancer Res 1986;102:18-37.
9. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant melanoma: II. Importance of UV light exposure. Int J Cancer 1988;42:319-24.
10. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2:487-90.
11. Garbe C, Weiss J, Kruger S, et al. The German Melanoma Registry and environmental risk factors implied. Recent Results Cancer Res 1993;128: 69-89.
12. Holly EA, Aston DA, Cress R, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995;141:923-33.
13. Swerdlow AJ, English JS, MacKie RM, et al. Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ 1988;297:647-50.
14. Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P. The association of cutaneous malignant melanoma with use of sunbeds and sunlamps. Am J Epidemiol 1990;131:232-43.
15. Autier P, Dore J-F, Lejeune F, et al. Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: an EORTC multicentre case-control study in Belgium, France and Germany. Int J Cancer 1994;58:809-13.
16. Westerdahl J, Olsson H, Masback A, et al. Use of sunbeds or sunlamps and malignant melanoma in Southern Sweden. Am J Epidemiol 1994;140:691-9.
17. Westerdahl J, Ingvar C, Masback A, Jonsson N, Olsson H. Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity. Br J Cancer 2000;82:1593-9.
18. Chen Y-T, Dubrow R, Zheng T, Barnhill RL, Fine J, Berwick M. Sunlamp use and risk of cutaneous malignant melanoma: a population-based, case-control study in Connecticut USA. Int J Epidemiol 1998;27:758-65.
19. Veierod MB, Weiderpass E, Thorn M, et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003;95:1530-8.
20. Stern RS, Nichols KT, Vakeva LH; for the PUVA Follow-up Study. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997;336: 1041-5.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
22. Petitti DB. Meta-analysis, decision analysis, and cost effectiveness analysis: methods for quantitative medicine. New York: Oxford University Press; 1994.
23. Young AR, Potten CS, Nikaido O, et al. Human melanocytes and keratinocytes exposed to UVB or UVA in vivo show comparable levels of thymine dimers. J Invest Dermatol 1998;111:936-40.
24. Fuchs J, Huflejt, Rothfuss LM, Wilson DS, Carcamo G, Packer L. Acute effects of near ultraviolet and visible light on the cutaneous antioxidant system. Photochem Photobiol 1989;50:739-44.
25. Fuchs J, Huflejt ME, Rothfuss LM, Wilson DS, Carcamo G, Packer L. Impairment of enzymatic and nonenzymatic antioxidants in skin by UVB irradiation. J Invest Dermatol 1989;93:769-73.
26. Sander CS, Hamm F, Elsner P, Thiele JJ. Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 2003;148: 913-22.
27. Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 2004;43:326-35.
28. Nelemans PJ, Rampen FHJ, Ruiter DJ, Verbeek ALM. An addition to the controversy on sunlight exposure and melanoma risk. J Clin Epidemiol 1995;48:1331-42.